Analyst Ratings for Spruce Biosciences, Inc. (SPRB)
SPRB Rating Summary
SPRB Price Target Summary
- Highest: $230.00 (Oppenheimer)
- Lowest: $123.00 (Guggenheim)
- Average: $162.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$162.25 (+272.6%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
Rating Score: 7.7 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | B.Riley | Madison El-Saadi | New Coverage | Buy (N/A) |
160.00 (N/A) |
51.74 (43.54) |
-15.85% | Details |
| 6/16/2026 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
123.00 (N/A) |
49.91 (43.54) |
-12.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
